Condition: Diabetic Foot Ulcer · Diabetic Foot Ulcer Neuropathic · Diabetic Foot Ulcer Ischemic · Sponsor: Community Pharmacology Services Ltd
The goal of this clinical trial is to compare safety and performance of the study device to the current typical NHS standards of care device. The main outcomes it aims to achieve are: Complete wound healing at 12 weeks (100% epithelialised) % Reduction in wound area at 12 weeks Participants will attend their NHS podiatry clinic appointment as normal and will be assigned either the study device or the current typical NHS standard of care device. Researchers will compare the study device group to the standard group to assess the outcomes mentioned previously.
This description comes directly from the study's public registry record.
Duncan Stang, MChS · 07554333493 · duncan.stang@lanarkshire.scot.nhs.uk
Kaye McIntyre, MsC · 01236 748748 · Kaye.McIntyre@lanarkshire.scot.nhs.uk
Always discuss trial participation with your own doctor first.
| NHS Lanarkshire | Airdrie, North Lanarkshire, United Kingdom | Recruiting |
| NHS Lothian | Livingston, West Lothian, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05762432